<DOC>
	<DOC>NCT00426452</DOC>
	<brief_summary>This study will determine the effect of acidic drugs such as proton-pump inhibitors on the pharmacokinetics of Vatalinib under fasting and fed conditions.</brief_summary>
	<brief_title>A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Inclusion criteria Healthy female Surgically sterile or postmenopausal At least a weight of 50 kg and have a body mass index (BMI) â‰¤33.0 Nonsmokers or those who smoke 25 cigarettes or less per day Exclusion criteria Use of certain prescription and over the counter drugs Having received an investigational drug within 30 days prior to dosing Donation of plasma or donation or loss of whole blood prior to administration of the study medication Any clinically significant laboratory tests Abnormal cardiac function A positive test for HIV, Hepatitis B or C A positive alcohol test or drug test Known allergy to Vatalinib or Omeprazole Any surgical or medical condition which might significantly alter the absorption, distribution, metabolism and excretion or drugs. Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Vascular endothelial growth factor receptor (VEGF-R) tyrosine kinase inhibitor</keyword>
	<keyword>Vatalinib</keyword>
	<keyword>Proton-pump inhibitors</keyword>
	<keyword>Omeprazole</keyword>
	<keyword>Healthy Postmenopausal Female Volunteers</keyword>
</DOC>